Samuel Cortese
Neurofeedback for attention-deficit/hyperactivity disorder: meta-Analysis of clinical and neuropsychological outcomes from randomized controlled trials
Cortese, Samuel; Ferrin, Maite; Brandeis, Daniel; Holtmann, Martin; Aggensteiner, Pascal; Daley, David; Santosh, Paramala; Simonoff, Emily; Stevenson, Jim; Stringaris, Argyris; Sonuga-Barke, Edmund J.S.
Authors
Maite Ferrin
Daniel Brandeis
Martin Holtmann
Pascal Aggensteiner
David Daley
Paramala Santosh
Emily Simonoff
Jim Stevenson
Argyris Stringaris
Edmund J.S. Sonuga-Barke
Abstract
Objective:
We performed meta-analyses of randomized controlled trials to examine the effects of neurofeedback on attention-deficit/hyperactivity disorder (ADHD) symptoms and neuropsychological deficits in children and adolescents with ADHD.
Method:
We searched PubMed, Ovid, Web of Science, ERIC, and CINAHAL through August 30, 2015. Random-effects models were employed. Studies were evaluated with the Cochrane Risk of Bias tool.
Results:
We included 13 trials (520 participants with ADHD). Significant effects were found on ADHD symptoms rated by assessors most proximal to the treatment setting, that is, the least blinded outcome measure (standardized mean difference [SMD]: ADHD total symptoms = 0.35, 95% CI = 0.11−0.59; inattention = 0.36, 95% CI = 0.09−0.63; hyperactivity/impulsivity = 0.26, 95% CI = 0.08−0.43). Effects were not significant when probably blinded ratings were the outcome or in trials with active/sham controls. Results were similar when only frequency band training trials, the most common neurofeedback approach, were analyzed separately. Effects on laboratory measures of inhibition (SMD = 0.30, 95% CI = −0.10 to 0.70) and attention (SMD = 0.13, 95% CI = −0.09 to 0.36) were not significant. Only 4 studies directly assessed whether learning occurred after neurofeedback training. The risk of bias was unclear for many Cochrane Risk of Bias domains in most studies.
Conclusion:
Evidence from well-controlled trials with probably blinded outcomes currently fails to support neurofeedback as an effective treatment for ADHD. Future efforts should focus on implementing standard neurofeedback protocols, ensuring learning, and optimizing clinically relevant transfer.
Citation
Cortese, S., Ferrin, M., Brandeis, D., Holtmann, M., Aggensteiner, P., Daley, D., Santosh, P., Simonoff, E., Stevenson, J., Stringaris, A., & Sonuga-Barke, E. J. (in press). Neurofeedback for attention-deficit/hyperactivity disorder: meta-Analysis of clinical and neuropsychological outcomes from randomized controlled trials. Journal of the American Academy of Child and Adolescent Psychiatry, 55(6), https://doi.org/10.1016/j.jaac.2016.03.007
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 28, 2016 |
Online Publication Date | Apr 1, 2016 |
Deposit Date | Jan 10, 2017 |
Publicly Available Date | Jan 10, 2017 |
Journal | Journal of the American Academy of Child & Adolescent Psychiatry |
Electronic ISSN | 0890-8567 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 55 |
Issue | 6 |
DOI | https://doi.org/10.1016/j.jaac.2016.03.007 |
Keywords | ADHD, neurofeedback, nonpharmacological treatment, meta-analysis, risk of bias |
Public URL | https://nottingham-repository.worktribe.com/output/777565 |
Publisher URL | http://www.sciencedirect.com/science/article/pii/S0890856716300958 |
Contract Date | Jan 10, 2017 |
Files
Neurofeedback for attention-deficit hyperactivity disorder.pdf
(475 Kb)
PDF
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search